Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Ann Endocrinol (Paris) ; 81(6): 551-560, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-33278378

RESUMEN

Several cases of Pneumocystosis pneumonia (PCP) have been reported in patients with hypercortisolism, mainly in patients with severe ectopic ACTH syndrome (EAS). We report 2 cases of PCP that did not develop until after starting treatment with metyrapone, one of which occurred in an outpatient with Cushing's disease (CD) without pulmonary symptoms before medical treatment for CD. Patient 1 presented as an outpatient with CD and severe hypercortisolism but nonetheless in good general condition. Treatment with metyrapone was started before pituitary surgery. Patient 2 had EAS due to prostate cancer. Respiratory failure in the two patients occurred 4 days and 30 days, respectively, after the start of metyrapone treatment. In both cases, chest CT showed bilateral interstitial infiltrates, and Pneumocystis jirovecii was found on bronchoalveolar lavage (BAL). A literature review was performed to identify risk factors for PCP in patients with CD: we identified 20 other cases of PCP in patients treated for hypercortisolism, including 16 patients with EAS. Ninety percent of patients had free urinary cortisol greater than 6 times the upper limit of normal (ULN). In conclusion, onset of PCP after initiation of anticortisolic therapy is not limited to patients with EAS, and may occur in CD patients with elevated cortisol levels, even if the patient remains in good general condition and has no pulmonary symptoms before treatment. In such patients, routine prophylactic treatment with trimethoprim/sulfamethoxazole (TMP/SMX) should be considered.


Asunto(s)
Síndrome de Cushing/tratamiento farmacológico , Síndrome de Cushing/microbiología , Metirapona/uso terapéutico , Neumonía por Pneumocystis/complicaciones , Síndrome de ACTH Ectópico/tratamiento farmacológico , Síndrome de ACTH Ectópico/microbiología , Adulto , Anciano , Anciano de 80 o más Años , Síndrome de Cushing/inmunología , Humanos , Síndromes de Inmunodeficiencia/microbiología , Masculino , Persona de Mediana Edad , Infecciones Oportunistas/complicaciones , Infecciones Oportunistas/prevención & control , Pacientes Ambulatorios , Neumonía por Pneumocystis/diagnóstico , Neumonía por Pneumocystis/prevención & control , Premedicación , Estudios Retrospectivos , Combinación Trimetoprim y Sulfametoxazol/administración & dosificación
2.
Ann Biol Clin (Paris) ; 75(1): 87-91, 2017 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-28132947

RESUMEN

We present the case of an Addison's disease revealed by a serious hyponatremia. The serum concentration of ACTH and 21-hydroxylase antibodies were increased and lead to the diagnosis. The cortisol blood level was lowered but required to take into account the stress induced by the hospitalisation of the patient. Addison's disease is characterized by the destruction of the adrenal cortex. Autoimmune adrenalitis is the main cause of adrenal insufficiency. Treatment involves normalisation of sodium concentration and corticosteroids replacement. With a good patient compliance, the survival rate of Addisonian patient is similar to that of the normal population. Management of patient requires vigilance because of the occurrence of others autoimmunes diseases during patient life.


Asunto(s)
Enfermedad de Addison/diagnóstico , Hiponatremia/diagnóstico , Enfermedad de Addison/sangre , Enfermedad de Addison/complicaciones , Hormona Adrenocorticotrópica/análisis , Hormona Adrenocorticotrópica/sangre , Autoanticuerpos/sangre , Coma/sangre , Coma/diagnóstico , Coma/etiología , Diagnóstico Diferencial , Humanos , Hidrocortisona/análisis , Hidrocortisona/sangre , Hiponatremia/sangre , Hiponatremia/complicaciones , Masculino , Persona de Mediana Edad , Índice de Severidad de la Enfermedad , Esteroide 21-Hidroxilasa/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...